154 related articles for article (PubMed ID: 16626861)
1. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes.
Veiga S; Leonelli E; Beelke M; Garcia-Segura LM; Melcangi RC
Neurosci Lett; 2006 Jul; 402(1-2):150-3. PubMed ID: 16626861
[TBL] [Abstract][Full Text] [Related]
2. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
3. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Roglio I; Bianchi R; Camozzi F; Carozzi V; Cervellini I; Crippa D; Lauria G; Cavaletti G; Melcangi RC
J Peripher Nerv Syst; 2009 Mar; 14(1):36-44. PubMed ID: 19335538
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury.
Roglio I; Bianchi R; Gotti S; Scurati S; Giatti S; Pesaresi M; Caruso D; Panzica GC; Melcangi RC
Neuroscience; 2008 Aug; 155(3):673-85. PubMed ID: 18625290
[TBL] [Abstract][Full Text] [Related]
6. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats.
Azcoitia I; Leonelli E; Magnaghi V; Veiga S; Garcia-Segura LM; Melcangi RC
Neurobiol Aging; 2003 Oct; 24(6):853-60. PubMed ID: 12927767
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
[TBL] [Abstract][Full Text] [Related]
8. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
9. Diabetes alters myelin lipid profile in rat cerebral cortex: Protective effects of dihydroprogesterone.
Cermenati G; Giatti S; Audano M; Pesaresi M; Spezzano R; Caruso D; Mitro N; Melcangi RC
J Steroid Biochem Mol Biol; 2017 Apr; 168():60-70. PubMed ID: 28167298
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats.
Pesaresi M; Maschi O; Giatti S; Garcia-Segura LM; Caruso D; Melcangi RC
Horm Behav; 2010 Jan; 57(1):46-55. PubMed ID: 19422828
[TBL] [Abstract][Full Text] [Related]
11. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves.
Melcangi RC; Azcoitia I; Ballabio M; Cavarretta I; Gonzalez LC; Leonelli E; Magnaghi V; Veiga S; Garcia-Segura LM
Prog Neurobiol; 2003 Sep; 71(1):57-66. PubMed ID: 14611868
[TBL] [Abstract][Full Text] [Related]
12. Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor.
Ino-ue M; Yokogawa H; Yamamoto M; Naka H; Kuriyama H
Exp Eye Res; 1998 Apr; 66(4):397-401. PubMed ID: 9593633
[TBL] [Abstract][Full Text] [Related]
13. Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats.
Pesaresi M; Giatti S; Calabrese D; Maschi O; Caruso D; Melcangi RC
J Mol Neurosci; 2010 Oct; 42(2):135-9. PubMed ID: 20349157
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural analysis of the cavernous and dorsal penile nerves in experimental diabetes.
Italiano G; Petrelli L; Marin A; Guidolin D; Venturin G; Pescatori ES; Aragona F; Pagano F; Triban C; Calabrò A
Int J Impot Res; 1993 Sep; 5(3):149-60. PubMed ID: 8124433
[TBL] [Abstract][Full Text] [Related]
15. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord.
Saredi S; Patte-Mensah C; Melcangi RC; Mensah-Nyagan AG
Neuroscience; 2005; 135(3):869-77. PubMed ID: 16111823
[TBL] [Abstract][Full Text] [Related]
16. Restricted hypotonic swelling of peripheral nerve myelin in streptozocin-induced diabetic rats.
Kirschner DA; Eichberg J
J Neurosci Res; 1994 Jun; 38(2):142-8. PubMed ID: 8078099
[TBL] [Abstract][Full Text] [Related]
17. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.
Cermenati G; Giatti S; Cavaletti G; Bianchi R; Maschi O; Pesaresi M; Abbiati F; Volonterio A; Saez E; Caruso D; Melcangi RC; Mitro N
J Neurosci; 2010 Sep; 30(36):11896-901. PubMed ID: 20826654
[TBL] [Abstract][Full Text] [Related]
18. Neuroactive steroids and peripheral neuropathy.
Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC
Brain Res Rev; 2008 Mar; 57(2):460-9. PubMed ID: 17543391
[TBL] [Abstract][Full Text] [Related]
19. Peripheral nerves: a target for the action of neuroactive steroids.
Melcangi RC; Cavarretta IT; Ballabio M; Leonelli E; Schenone A; Azcoitia I; Miguel Garcia-Segura L; Magnaghi V
Brain Res Brain Res Rev; 2005 Apr; 48(2):328-38. PubMed ID: 15850671
[TBL] [Abstract][Full Text] [Related]
20. Morphometry of the peripheral nerve in experimental diabetes mellitus.
Ochodnická E; Ochodnický M; Ochodnický P; Belej K; Fuseková E; Boseĺová L
Sb Lek; 2001; 102(2):173-8. PubMed ID: 12092102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
